SEEK Limited (SKLTY)

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	5,533	5,077	5,121	5,125	8,764	5,329
Market Cap Growth	-1.54%	-0.86%	-0.07%	-41.52%	64.44%	2.16%
Enterprise Value	6,315	5,958	5,955	6,130	9,907	6,495
Last Close Price	30.75	27.87	28.01	27.92	44.48	27.21
PE Ratio	698.49	-	7.36	44.06	15.54	-
PS Ratio	8.42	7.02	6.65	6.66	15.37	11.86
PB Ratio	3.23	2.95	2.85	3.93	6.09	5.61
P/TBV Ratio	8.53	7.83	7.25	23.23	25.73	-
P/FCF Ratio	27.13	24.06	24.54	19.78	39.99	26.35
P/OCF Ratio	26.37	23.14	24.07	18.75	33.73	25.73
EV/Sales Ratio	9.21	8.24	7.73	7.97	17.38	14.46
EV/EBITDA Ratio	26.76	28.14	21.08	22.23	49.83	42.11
EV/EBIT Ratio	31.38	29.85	21.91	22.97	57.53	60.38
EV/FCF Ratio	30.97	28.24	28.54	23.66	45.21	32.12
Debt / Equity Ratio	0.51	0.55	0.56	0.83	0.70	1.47
Debt / EBITDA Ratio	4.48	4.20	3.40	3.77	4.79	8.71
Debt / FCF Ratio	4.30	4.46	4.80	4.20	4.59	6.91
Asset Turnover	0.21	0.22	0.23	0.24	0.17	0.15
Quick Ratio	0.67	0.81	0.87	0.81	0.98	0.71
Current Ratio	0.84	0.86	0.92	1.98	1.82	0.85
Return on Equity (ROE)	1.86%	-2.27%	10.03%	12.63%	6.34%	-8.03%
Return on Assets (ROA)	3.27%	3.74%	5.13%	5.20%	3.22%	2.27%
Return on Capital (ROIC)	3.94%	4.57%	6.65%	7.19%	4.31%	2.90%
Return on Capital Employed (ROCE)	5.80%	7.00%	8.70%	10.90%	6.90%	4.60%
Earnings Yield	0.14%	-1.33%	13.59%	2.27%	6.44%	-1.47%
FCF Yield	3.69%	4.16%	4.08%	5.05%	2.50%	3.79%
Dividend Yield	1.36%	0.84%	1.12%	1.09%	0.34%	0.33%
Payout Ratio	975.00%	-	15.26%	90.17%	6.09%	-
Buyback Yield / Dilution	0.16%	0.14%	-0.23%	-0.09%	-1.01%	0.43%
Total Shareholder Return	1.52%	0.97%	0.89%	1.00%	-0.68%	0.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.